African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2285

Full Length Research Paper

The role of beta 2 – agonists in improving exercise response in hypertensive patients

Adesola, Adefemi Muritala
  • Adesola, Adefemi Muritala
  • Department of Physiology, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.
  • Google Scholar


  •  Received: 09 May 2013
  •  Accepted: 29 August 2014
  •  Published: 29 September 2014

References

 

Chick TW, Halperin AK, Gacek EM (1988). The effect of antihypertensive medications on exercise performance: a review. Med. Sci. Sports Exerc. 20:447-454.
Crossref
 
Folklow B (1982). Physiological aspects of primarily hypertension. Phys. Rev. 62:347-504.
 
Freis ED (1960). Hemodynamics of hypertension. Physiol. Rev. 40:27-54.
Pubmed
 
Frohlic ED, Ketelhut R, Kelser UR, Losem CJ, Messerli FH (1991). Hemodynamic effects of celiprolol in essential hypertension. Am. J. Cardiol. 68:509-514.
Crossref
 
Head A, Maxwell S, Kendall MJ (1997). Exercise metabolism in healthy volunteers taking celiprolol, atenolol and placebo 31(2):120-5
 
Kalser P, Tesch DA, Frisk-Holmberg M, Juhlin-Dannfelt A, Kauser L (1986). Effect of beta-1 selective and non-selective beta-blockade on work capacity and muscle metabolism. Clin. Physiol. 6:197-207.
Crossref
 
Kokkinos P, Chrysohoou C, Panagiotakos D, Narayan P, Greenberg M, Singh S (2006). Beta-blockade mitigates exercise blood pressure in hypertensive male patents. 47(4):794-8
 
Kowalchuk JM, Klein CS, Hughson RL (1990). The effect of beta-adrenergic blockade on leg blood flow with repeated maximal contractions of the triceps surel muscle group in man. Eur. J. Appl. Physiol. 60:360-364.
Crossref
 
Lund-Johansen P (1980). State of the art review. Hemodynamic in essential hypertension. Clin. Sci. 59:343-354.
 
Lund-Johansen P (1983). Central hemodynamic effects of beta-blockers in hypertension. A comparison between atenolol, metoprolol, timolol, phenbutolol, alprenolol, pindolol and bunitrolol. Eur. Heart J. 4(Suppl. D):1-12.
Crossref
 
Lund-Johansen P (1987). Exercise and antihypertensive therapy Am. J. Cardiol. 59:98A-107A.
Crossref
 
Mancia G, Grassi G, Parati G (1986). Effect of celiprolol on reflex control of the cardiovascular system in essential hypertension. J. Cardiovasc. Pharmocol. 8(Suppl. 4):S67-S74.
Crossref
 
McLenaghan JM, Grant S, Ford I, Hendersen E, Dargh HJ (1991). Submaximal, but not maximal exercise testing detects differences in the effects of β-blockers during treadmill exercise. A study of celoprolol and atenolol II. Am. Heart J. 121:691-696.
Crossref
 
Pawelczyk JA, Hanei B, Pawelczyk RA, Warberg J, Secher NH (1992). Leg vasoconstriction during dynamic exercise with reduced cardiac output. J. Appl. Physio. 73:1838-1846.
Pubmed
 
Petersen ES, Whipp BJ, Davis JA, Huntsmann DJ, Brown HV, Wasserman K (1983). Effects of beta-adrenergic blockage on ventilation and gas exchange during exercise in humans J. Appl. Physiol. 54:1306-1313.
Pubmed
 
Prichard BNC, Tomlinson B (1986). The additional properties of beta adrenoceptor blocking drugs. J. Cardiovasc. Pharmacol. 8(Suppl. 4):S1-S15.
Crossref
 
Rogers GG, Rosendorff C, Goodman C, Radford HM (1988). Effects of angiotensin converting enzyme inhibition and beta-blockade on exercise responses in hypertensive patients. J. Hypertens. 6(Suppl.4):S662-S665.
Crossref
 
Rowell LB, O'Leary D (1990). Reflex control of the circulation during exercise: chemoreflexes and mechanoreflexes. J. Appl. Physiol. 69:407-418.
Pubmed
 
Thompson PD, Cullinane EM, Nugent AM, Sady MA, Sady SP (1989). Effect of atenolol or parosin on maximal exercise performance in hypertensive joggers Am. J. Med. 86(Suppl. 1B):104-109.
Crossref
 
Trimarco B, Lembo G, DE N, Luca (1987). Effects of celiprolol on systemic and forearm circulation in hypertensive patients a double-blind cross-over study versus metoprolol. J. Clin. Pharmacol. 27:593-600.
Crossref
 
Van Baak MA, Koene FMM, Verstappen FTJ (1988). Exercise hemodynamic and maximal exercise capacity during beta-adrenergic blockade in normotensive and hypertensive subjects. Br. J. Clin. Pharmacol. 25:169-178.
Crossref
 
Wheeldon NM, McDevitt DG, Lipworth BJ (1992). Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects Br. J. Clin. Pharmacol. 34:337-343.
Crossref
 
Whitney RJ (1953). The measurement of volume changes in human limbs. J. physiol. 121:1-27
Pubmed
 
Wilmore JH, Freund BJ, Joyner MJ (1985). Acute response to sub-maximal and maximal exercise consequent to beta-adrenergic blockage: implications for the prescriptions of exercise. Am. J. Cardiol. 55:135D-141D.
Crossref
 
Wolf PS, Smith RD, Khandwala A (1985). Celiprolol-Pharmacological profile of an unconventional beta-blocker. Br. J. Clin. Pract. 39(6 Suppl. 40):5-11.